• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 24-38 of 163 results

2 Power of Attorney: Power of Attorney

Document IPR2018-00530, No. 2 Power of Attorney - Power of Attorney (P.T.A.B. Jan. 24, 2018)

cite Cite Document
Analyze

10 Preliminary Response: Patent Owners Preliminary Response

Document IPR2017-01673, No. 10 Preliminary Response - Patent Owners Preliminary Response (P.T.A.B. Oct. 11, 2017)

cite Cite Document
Analyze

... CORRECTED PETITION FOR INTER PARTES REVIEW OF US PATENT NO 6,790,459 UNDER 35 USC 311...

Document IPR2017-01673, No. 8 Corrected Petition - CORRECTED PETITION FOR INTER PARTES REVIEW OF US PATENT NO 6,790,459 UNDER 35 USC 311 319 AND 37 CFR 421 80, 42100 123 (P.T.A...

cite Cite Document
Analyze

6 Mandatory Notice: PO Mandatory Notices

Document IPR2017-01673, No. 6 Mandatory Notice - PO Mandatory Notices (P.T.A.B. Jul. 10, 2017)

cite Cite Document
Analyze

3 Power of Attorney: Andrx Power of Attorney

Document IPR2017-01673, No. 3 Power of Attorney - Andrx Power of Attorney (P.T.A.B. Jul. 10, 2017)

cite Cite Document
Analyze

5 Power of Attorney: Shionogi Power of Attorney

Document IPR2017-01673, No. 5 Power of Attorney - Shionogi Power of Attorney (P.T.A.B. Jul. 10, 2017)

cite Cite Document
Analyze

4 Power of Attorney: Teva Power of Attorney

Document IPR2017-01673, No. 4 Power of Attorney - Teva Power of Attorney (P.T.A.B. Jul. 10, 2017)

cite Cite Document
Analyze

2 Power of Attorney: Power of Attorney for Patent No 6,790,459

Document IPR2017-01673, No. 2 Power of Attorney - Power of Attorney for Patent No 6,790,459 (P.T.A.B. Jun. 23, 2017)

cite Cite Document
Analyze

2001 Exhibit: April 27, 2004 Letter from the FDA Approving NDA 21 574

Document IPR2018-00530, No. 2001-22 Exhibit - April 27, 2004 Letter from the FDA Approving NDA 21 574 (P.T.A.B. Jun. 7, 2018)

cite Cite Document
Analyze

2003 Exhibit: Aurobindo Pharma USA Inc v Andrx Labs, LLC, No IPR2017 01673, P...

Document IPR2018-00530, No. 2003-24 Exhibit - Aurobindo Pharma USA Inc v Andrx Labs, LLC, No IPR2017 01673, Paper 11 PTAB December 29, 2017 (P.T.A.B. Jun. 7, 2018)

cite Cite Document
Analyze

2002 Exhibit: April 27, 2004 Approved Fortamet Label

Document IPR2018-00530, No. 2002-23 Exhibit - April 27, 2004 Approved Fortamet Label (P.T.A.B. Jun. 7, 2018)

cite Cite Document
Analyze

2003 Exhibit: Aurobindo Pharma USA Inc v Andrx Labs, LLC, No IPR2017 01673, P...

Document IPR2018-00530, No. 2003 Exhibit - Aurobindo Pharma USA Inc v Andrx Labs, LLC, No IPR2017 01673, Paper 11 PTAB December 29, 2017 (P.T.A.B. Jun. 7, 2018)

cite Cite Document
Analyze

2002 Exhibit: April 27, 2004 Approved Fortamet Label

Document IPR2018-00530, No. 2002 Exhibit - April 27, 2004 Approved Fortamet Label (P.T.A.B. Jun. 7, 2018)

cite Cite Document
Analyze

2001 Exhibit: April 27, 2004 Letter from the FDA Approving NDA 21 574

Document IPR2018-00530, No. 2001 Exhibit - April 27, 2004 Letter from the FDA Approving NDA 21 574 (P.T.A.B. Jun. 7, 2018)

cite Cite Document
Analyze

1011 Exhibit: Exhibit 1011

Document IPR2018-00530, No. 1011-11 Exhibit - Exhibit 1011 (P.T.A.B. Jan. 24, 2018)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 ... 10 11 12 >>